Literature DB >> 11342471

Chromosomal location, exon structure, and vascular expression patterns of the human PDGFC and PDGFD genes.

M Uutela1, J Laurén, E Bergsten, X Li, N Horelli-Kuitunen, U Eriksson, K Alitalo.   

Abstract

BACKGROUND: Platelet-derived growth factor (PDGF), which is a major mitogen for vascular smooth muscle cells and has been implicated in the pathogenesis of arteriosclerosis, is composed of dimers of PDGF-A and PDGF-B polypeptide chains, encoded by different genes. Here, we have analyzed the chromosomal localization, structure, and expression of 2 newly identified human genes of the PDGF family, called PDGFC and PDGFD. METHODS AND
RESULTS: We used fluorescence in situ hybridization to locate PDGFC and PDGFD in chromosomes 4q32 and 11q22.3 to 23.2, respectively. Exon structures of PDGFC and PDGFD were determined by sequencing from genomic DNA clones. The coding region of PDGFC consists of 6 and PDGFD of 7 exons, of which the last 2 encode the C-terminal PDGF cystine knot growth factor homology domain. An N-terminal CUB domain is encoded by exons 2 and 3 of both genes, and a region of proteolytic cleavage involved in releasing and activating the growth factor domain is located in exon 4 in PDGFC and exon 5 in PDGFD. PDGF-C was expressed predominantly in smooth muscle cells and PDGF-D in fibroblastic adventitial cells, and both genes were active in cultured endothelial cells and in a variety of tumor cell lines. Both PDGF-C and PDGF-D also stimulated human coronary artery smooth muscle cells.
CONCLUSIONS: PDGFC and PDGFD have similar genomic structures, which resemble those of the PDGFA and PDGFB genes. Their expression in the arterial wall and cultured vascular cells suggests that they can transduce proliferation/migration signals to pericytes and smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342471     DOI: 10.1161/01.cir.103.18.2242

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  26 in total

1.  Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice.

Authors:  Koichi Kozaki; Wolfgang E Kaminski; Jingjing Tang; Stan Hollenbach; Per Lindahl; Carol Sullivan; Jin-Chen Yu; Keith Abe; Paul J Martin; Russell Ross; Christer Betsholtz; Neill A Giese; Elaine W Raines
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

2.  Over-expression of PDGF-C using a lung specific promoter results in abnormal lung development.

Authors:  Ying Zhuo; Gary W Hoyle; Bin Shan; Dawn R Levy; Joseph A Lasky
Journal:  Transgenic Res       Date:  2006-07-09       Impact factor: 2.788

Review 3.  The platelet-derived growth factor receptor as a therapeutic target.

Authors:  Nancy L Lewis
Journal:  Curr Oncol Rep       Date:  2007-03       Impact factor: 5.075

4.  Platelet-derived growth factor B-chain of hematopoietic origin is not necessary for granulation tissue formation and its absence enhances vascularization.

Authors:  B S Buetow; J R Crosby; W E Kaminski; R K Ramachandran; P Lindahl; P Martin; C Betsholtz; R A Seifert; E W Raines; D F Bowen-Pope
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

5.  Platelet-derived growth factor-DD targeting arrests pathological angiogenesis by modulating glycogen synthase kinase-3beta phosphorylation.

Authors:  Anil Kumar; Xu Hou; Chunsik Lee; Yang Li; Arvydas Maminishkis; Zhongshu Tang; Fan Zhang; Harald F Langer; Pachiappan Arjunan; Lijin Dong; Zhijian Wu; Linda Y Zhu; Lianchun Wang; Wang Min; Peter Colosi; Triantafyllos Chavakis; Xuri Li
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

Review 6.  Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders.

Authors:  Sebastian A Lewandowski; Linda Fredriksson; Daniel A Lawrence; Ulf Eriksson
Journal:  Pharmacol Ther       Date:  2016-08-12       Impact factor: 12.310

7.  Platelet-derived growth factor-D promotes fibrogenesis of cardiac fibroblasts.

Authors:  Tieqiang Zhao; Wenyuan Zhao; Yuanjian Chen; Victoria S Li; Weixin Meng; Yao Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

8.  Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy.

Authors:  Annica Pontén; Xuri Li; Peter Thorén; Karin Aase; Tobias Sjöblom; Arne Ostman; Ulf Eriksson
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

9.  Tissue plasminogen activator is a potent activator of PDGF-CC.

Authors:  Linda Fredriksson; Hong Li; Christina Fieber; Xuri Li; Ulf Eriksson
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

10.  Unrestricted somatic stem cells from human umbilical cord blood grow in serum-free medium as spheres.

Authors:  Faten Zaibak; Paul Bello; Jennifer Kozlovski; Duncan Crombie; Haozhi Ang; Mirella Dottori; Robert Williamson
Journal:  BMC Biotechnol       Date:  2009-12-15       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.